About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read more
- Annual Report 2018PDF - 3.6MB
We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work.
Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.
What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
Pharmaceuticals
Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.
Consumer Healthcare
Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands in the Pain relief, Respiratory, Digestive health, Oral health, Nutrition and Skin health categories.
On 19 December 2018 we announced our agreement with Pfizer to form a new world-leading Consumer Healthcare Joint Venture. Within 3 years of the closing of the transaction, we intend to separate the Joint Venture via a demerger. With our future intention to separate, the transaction also presents a clear pathway forward for us to create a new global Pharmaceuticals/Vaccines company, and a new world-leading Consumer Healthcare company. Find out more
How we do it
Everyone at GSK is focused on 3 priorities – Innovation, Performance, Trust
Innovation
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
-
£3.9bn
R&D investment in 2018
-
33*
of the 46* new medicines now in development targeting modulation of the immune system
-
16*
immuno-oncology assets now in clinical development
Performance
We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.
-
£30.8bn
total turnover in 2018
-
£8.7bn
adjusted operating profit in 2018
-
£5.7bn
free cash flow in 2018
-
£3.9bn
dividends paid in 2018
Trust
We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer.
-
78%
employee engagement score on our latest employee survey
-
£224m
donated in 2018 to community health programmes
-
1st
in Access to Medicines Index since the assessment began in 2008
*Includes M7824, the subject of the alliance with Merck KGaA, Darmstadt, Germany, expected to close in Q1 2019.
Find out more about us
-
Our history
-
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
-
Governance
At GSK we are committed to operating at the highest standards of corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders.
-
Policies, codes and standards
Find out more about the GSK Code of Conduct and our Anti-Bribery and Corruption programme
